BMI30

BMI30 is a term used to refer to a body mass index of 30.0 or higher, which marks the threshold for obesity in most guidelines. The body mass index (BMI) is a simple index of weight-for-height that is commonly used to classify underweight, normal weight, overweight, and obesity. It is calculated as weight in kilograms divided by the square of height in meters (kg/m^2).

BMI categories include: 30.0–34.9 obesity class I; 35.0–39.9 class II; 40.0 and above class III.

BMI30 is used in clinical practice to screen for obesity-related health risks and to determine eligibility for certain interventions, including pharmacotherapy and bariatric surgery in some guidelines.

Limitations: BMI does not measure body fat percentage or distribution, and may misclassify muscular individuals or those with high visceral fat but normal weight; it may also not account for age, sex, or ethnicity.

Health risks: higher BMI is associated with increased risk of type 2 diabetes, cardiovascular disease, hypertension, dyslipidemia, sleep apnea, certain cancers, and osteoarthritis.

Management: effective strategies include sustained weight loss through a combination of caloric reduction and physical activity; typical goals include a 5–10% reduction in body weight over 6–12 months. Pharmacologic therapy and bariatric/metabolic surgery are considered for BMI at or above 30 with comorbidities or BMI at or above 40 (or 35 with comorbidities) in many guidelines.